THU-227 - Direct Antiviral Combination Treatment According to Presence of Baseline Ravs in NS3, NS5A and NS5B Leads to High SVR Rates in Non-Cirrhotic and Cirrhotic Genotype 1 Infected Patients

Autor: Peiffer, K.-H., Susser, S., Dietz, J., Berkowski, C., Perner, D., Passmann, S., Raeder, M., Vermehren, J., Lange, C., Klein, S., Weiler, N., Zeuzem, S., Sarrazin, C.
Zdroj: In Journal of Hepatology 2016 64(2) Supplement:S404-S404
Databáze: ScienceDirect